Free Trial

Keros Therapeutics (KROS) Insider Trading & Ownership

Keros Therapeutics logo
$13.35 -0.14 (-1.04%)
As of 06/30/2025 04:00 PM Eastern

Keros Therapeutics (NASDAQ:KROS) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
22.90%
Number Of
Insiders Buying
(Last 12 Months)
1
Amount Of
Insider Buying
(Last 12 Months)
$9.46M
Number Of
Insiders Selling
(Last 12 Months)
1
Amount Of
Insider Selling
(Last 12 Months)
$11.00M
Get KROS Insider Trade Alerts

Want to know when executives and insiders are buying or selling Keros Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

KROS Insider Buying and Selling by Quarter

Keros Therapeutics Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
4/9/2025Adar1 Capital Management, LlcMajor ShareholderBuy934,258$10.13$9,464,033.54  
8/13/2024Carl L GordonDirectorSell250,000$44.01$11,002,500.00  
(Data available from 1/1/2013 forward)

KROS Insider Trading Activity - Frequently Asked Questions

The list of insiders at Keros Therapeutics includes Adar1 Capital Management, Llc, Carl L Gordon, Jennifer Lachey, and Keith Regnante. Learn more on insiders at KROS.

22.90% of Keros Therapeutics stock is owned by insiders. Learn more on KROS's insider holdings.

The following insider purchased KROS shares in the last 24 months: Adar1 Capital Management, Llc ($9,464,033.54).

Insiders have purchased a total of 934,258 KROS shares in the last 24 months for a total of $9,464,033.54 bought.

The following insider sold KROS shares in the last 24 months: Carl L Gordon ($11,002,500.00).

Insiders have sold a total of 250,000 Keros Therapeutics shares in the last 24 months for a total of $11,002,500.00 sold.



This page (NASDAQ:KROS) was last updated on 7/1/2025 by MarketBeat.com Staff
From Our Partners